BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25287062)

  • 1. A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension.
    Paulin R; Sutendra G; Gurtu V; Dromparis P; Haromy A; Provencher S; Bonnet S; Michelakis ED
    Circ Res; 2015 Jan; 116(1):56-69. PubMed ID: 25287062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Potus F; Ruffenach G; Dahou A; Thebault C; Breuils-Bonnet S; Tremblay È; Nadeau V; Paradis R; Graydon C; Wong R; Johnson I; Paulin R; Lajoie AC; Perron J; Charbonneau E; Joubert P; Pibarot P; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2015 Sep; 132(10):932-43. PubMed ID: 26162916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA208/Mef2 and TNF-α in right ventricular dysfunction: the transition from hypertrophy to failure.
    Tang H; Fernandez RA; Yuan JX
    Circ Res; 2015 Jan; 116(1):6-8. PubMed ID: 25552686
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
    Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension.
    Ruiter G; Ying Wong Y; de Man FS; Louis Handoko M; Jaspers RT; Postmus PE; Westerhof N; Niessen HW; van der Laarse WJ; Vonk-Noordegraaf A
    J Heart Lung Transplant; 2013 Feb; 32(2):231-40. PubMed ID: 23142560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
    Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
    J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle.
    Chouvarine P; Legchenko E; Geldner J; Riehle C; Hansmann G
    J Mol Med (Berl); 2019 Oct; 97(10):1427-1438. PubMed ID: 31338525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
    Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
    Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin axis is upregulated in human and rat right ventricular hypertrophy.
    Nagendran J; Sutendra G; Paterson I; Champion HC; Webster L; Chiu B; Haromy A; Rebeyka IM; Ross DB; Michelakis ED
    Circ Res; 2013 Jan; 112(2):347-54. PubMed ID: 23233754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload.
    Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.
    Pullamsetti SS; Doebele C; Fischer A; Savai R; Kojonazarov B; Dahal BK; Ghofrani HA; Weissmann N; Grimminger F; Bonauer A; Seeger W; Zeiher AM; Dimmeler S; Schermuly RT
    Am J Respir Crit Care Med; 2012 Feb; 185(4):409-19. PubMed ID: 22161164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
    Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
    Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of Ryanodine Receptors Promotes Ca
    Huang Y; Lei C; Xie W; Yan L; Wang Y; Yuan S; Wang J; Zhao Y; Wang Z; Yang X; Qin X; Fang Q; Fang L; Guo X
    Hypertension; 2021 Jan; 77(1):59-71. PubMed ID: 33249863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
    Joshi SR; Dhagia V; Gairhe S; Edwards JG; McMurtry IF; Gupte SA
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H689-98. PubMed ID: 27422986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
    J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
    Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ
    Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Jani V; Aslam MI; Fenwick AJ; Ma W; Gong H; Milburn G; Nissen D; Cubero Salazar IM; Hanselman O; Mukherjee M; Halushka MK; Margulies KB; Campbell KS; Irving TC; Kass DA; Hsu S
    Circulation; 2023 Jun; 147(25):1919-1932. PubMed ID: 37194598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.